SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1352458508092353v1
14/8/1120    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sundström, P
Right arrow Articles by Hallmans, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundström, P
Right arrow Articles by Hallmans, G
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Multiple Sclerosis
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study

P Sundström1*, L Nyström2, E Jidell3, and G Hallmans4

1 Department of Neurology, Umeå University Hospital, Umea, Sweden
2 Department of Public Health and Clinical Medicine, Epidemiology and Public Health Sciences, Umeå University, Umea, Sweden
3 Department of Transfusion Medicine, Umeå University Hospital, Umea, Sweden
4 Department of Public Health and Clinical Medicine, Nutritional Research, Umea University, Umea, Sweden

* To whom correspondence should be addressed.


  Abstract

Objectives and methods

The interaction between the two best documented risk factors (human leukocyte antigen [HLA] class II [DRB1*1501 positivity] and Epstein-Barr virus [elevated Epstein-Barr nuclear antigen 1 (EBNA-1) antibody reactivity]) for multiple sclerosis (MS) was studied in a case-control study of biobank samples from 109 MS cases and 212 matched referents.

Results

Multivariate logistic regression analysis showed that both were statistically significant in both sexes. HLA DRB1*1501-positive referents had higher EBNA-1 reactivity than HLA-negative referents. Less EBNA-1 reactivity was required to increase the MS risk in HLA DRB1*1501-positives than in HLA-negatives.

Conclusion

We suggest that HLA DRB1*1501-positive individuals have an increased vulnerability to EBV-induced autoimmunity.

Key Words: EBNA-1, epstein-barr virus, HLA DRB1*1501, multiple sclerosis

First published on June 23, 2008, doi:10.1177/1352458508092353

Multiple Sclerosis 2008;14:1120.

A more recent version of this article appeared on September 1, 2008

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Mult SclerHome page
2009 ACTRIMS ABSTRACTS: Oral Presentations
Multiple Sclerosis, November 1, 2009; 15(11): 1387 - 1395.
[PDF]


Advertisement